首页> 外文期刊>BMC Nephrology >Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study
【24h】

Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study

机译:进行性IgA肾病并在十年内发展为终末期肾脏疾病的危险因素:病例对照研究

获取原文
           

摘要

Background There were few related studies aiming to severe IgA nephropathy (IgAN) which could progress rapidly to end stage renal disease (ESRD) within ten years. To find valuable clinical or pathological factors and promising precautions is essential. Methods A single center case–control study was performed. Fifty ESRD patients with the primary cause of IgAN and a short renal survival time of less than ten years after diagnose were enrolled in the case group. One hundred IgAN patients with a renal survival time of more than ten years were enrolled in the control group. IgA Oxford classification scores, clinical data at baseline and during the follow-up were collected. Multivariate logistic regression was used to investigate factors associated with the development of ESRD. Results There were significant differences in baseline clinical data between these two groups, as well as the constituent ratio of Oxford MEST-score. Distinct differences were observed in time-average uric acid(TA-UA), time-average hemoglobin(TA-Hb), time-average albumin(TA-Alb), time-average total cholesterol(TA-TC) and time-average urinary protein(TA-P) during the follow-up. In multivariate logistic models, IgA Oxford score M1(OR?=?5.10, P =?0.018) and eGFR(OR?=?0.97, P =?0.039) at biopsy, TA-UA (OR?=?2.06, P =?0.026) and TA-Hb (OR?=?0.53, P =?0.022) during the follow-up were identified independent factors for developing ESRD. Conclusion IgAN patients with pathological assessment of M1, low baseline eGFR, TA-Hb and high TA-UA were more likely to progress to ESRD, and should be paid more attention. Appropriate regulations of UA, Hb and urine protein after diagnose may be a promising treatment. Keyword IgA nephropathy Oxford classification End stage renal disease Follow-up clinical data
机译:背景鲜有针对严重IgA肾病(IgAN)的相关研究,该病可在十年内迅速发展为晚期肾病(ESRD)。寻找有价值的临床或病理因素和有希望的预防措施至关重要。方法进行一项中心病例对照研究。病例组共入选了50例ESRD患者,这些患者是IgAN的主要病因,诊断后肾脏生存时间少于10年。对照组中有100名IgAN患者的肾脏生存时间超过10年。收集IgA牛津分类评分,基线和随访期间的临床数据。多因素logistic回归用于研究与ESRD发展相关的因素。结果两组之间的基线临床数据以及牛津MEST评分的构成比均存在显着差异。时间平均尿酸(TA-UA),时间平均血红蛋白(TA-Hb),时间平均白蛋白(TA-Alb),时间平均总胆固醇(TA-TC)和时间平均存在明显差异随访期间尿蛋白(TA-P)。在多变量Logistic模型中,活检时IgA牛津评分为M1(OR?=?5.10,P =?0.018)和eGFR(OR?=?0.97,P =?0.039),TA-UA(OR?=?2.06,P =随访期间确定的[0.026]和TA-Hb(OR == 0.53,P = <0.022)是发展ESRD的独立因素。结论病理评估为M1,基线eGFR较低,TA-Hb和TA-UA较高的IgAN患者更有可能发展为ESRD,应引起更多重视。诊断后适当的UA,Hb和尿蛋白法规可能是有前途的治疗方法。关键词IgA肾病牛津分类晚期肾脏疾病随访临床资料

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号